Veradigm | MDRX - Zahlungsmittel Und Äquivalente





Zahlungsmittel Und Äquivalente Veränderung Datum
Alcidion AUD 11.8M 2.84M 2024-06
Ambu A/S DKK 691M 44M 2026-03
Amplifon EUR 309.56M 673K 2026-03
Cardinal Health USD 3.94B 1.16B 2026-03
Centene USD 24.15B 2.89B 2026-06
Charles River Laboratories USD 192.02M 195K 2026-06
Cigna USD 6.3B 742M 2026-06
Coloplast 911M 497M 2023-09
Convatec Group USD 64.7M 32.2M 2024-12
CVS Health USD 11.33B 1.79B 2026-06
Diasorin EUR 173.08M 3.51M 2025-06
Elevance Health USD 10.23B 575M 2026-06
General Electric Aerospace USD 9.35B 1.64B 2026-06
Gulf Medical Proj AED 74.52M 101.52M 2025-03
Humana USD 6.89B 1.94B 2026-06
IQVIA Holdings USD 1.91B 38M 2026-06
Laboratory Of America USD 141.8M 839.3M 2026-06
Maximus USD 56.95M 100.5M 2026-06
McKesson USD 5.16B 1.19B 2026-06
Med Life RON 168.41M 16.94M 2026-03
Molina Healthcare USD 4.99B 329M 2026-06
Omnicell USD 292.16M 52.94M 2026-06
Oriola-kd EUR 107.6M 13.9M 2025-09
Owens Minor USD 336.88M 54.89M 2026-03
Quest Diagnostics USD 626M 233M 2026-06
Rede D'or Sao Luiz BRL 5.41B 1.7B 2026-03
Siemens Healthineers EUR 1.91B 235M 2026-03
Sonova Holding CHF 413.9M 134.3M 2023-06
Supermax Corporation Bhd MYR 637.59M 217.66M 2026-03
UnitedHealth USD 31.47B 239M 2026-06
Veeva Systems USD 1.9B 475.35M 2026-03
Veradigm USD 492.6M 7.57M 2022-09
Xerox USD 585M 73M 2026-03